Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | DPYD | Q12882 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Z)-1,2-Diphenylethene SCHEMBL28428310 | 0.78 | CA1 (0.70) | MAOBNFE2L2TRPA1ALDH1A1MAPT | |
| SCHEMBL10582579 | 0.76 | CA1 (0.34) | ALDH1A1MAPTF2NPC1POLB | |
| SCHEMBL29849865 | 0.76 | NFE2L2 (0.46) | MAOBNFE2L2TRPA1ALDH1A1MAPT | |
| SCHEMBL10582572 | 0.76 | CA1 (0.34) | ALDH1A1MAPTF2NPC1POLB | |
| SCHEMBL44502 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL7653150 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 | |
| SCHEMBL44503 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL7653143 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 | |
| SCHEMBL6360540 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 | |
| SCHEMBL9540538 | 0.73 | NFE2L2 (0.68) | MAOBNFE2L2TRPA1MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702039-A1 | METHOD OF PRODUCING STYRYLPYRONES AND CHALCONES | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | claimed |
| WO-2024224080-A1 | METHOD OF PRODUCING STYRYLPYRONES AND CHALCONES | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | claimed |
| CN-111333661-A | Phenylpyrone derivative of Phellinus ribis, and preparation method and application thereof | 吴浩然 | 2020-06-26 | — | — | CN | claimed |
| US-20260085054-A1 | DERIVATIVE OF HISPIDIN FROM SANGHUANGPORUS SANGHUANG, AND PREPARATION METHOD AND USE THEREOF | UNIV CHINA THREE GORGES CTGU (CN) | 2026-03-26 | — | — | US | disclosed |
| US-20260085054-A1 | DERIVATIVE OF HISPIDIN FROM SANGHUANGPORUS SANGHUANG, AND PREPARATION METHOD AND USE THEREOF | UNIV CHINA THREE GORGES CTGU (CN) | 2026-03-26 | — | — | US | disclosed |
| EP-4702038-A1 | METHOD OF PRODUCING POLYPHENOLS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702039-A1 | METHOD OF PRODUCING STYRYLPYRONES AND CHALCONES | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| CN-121517382-A | Hispidin derivative in Phellinus linteus and preparation method and application thereof | 三峡大学 | 2026-02-13 | — | — | CN | disclosed |
| CN-120004837-A | Phellinus pyranone compound Interfungin A, separation and purification method of compound and application of compound as anticancer drug | 浙江省农业科学院 | 2025-05-16 | — | — | CN | disclosed |
| CN-114573539-B | Method for preparing compound Phellibaumin D from phellinus linteus medicinal material | 中国科学院大连化学物理研究所 | 2024-11-05 | — | — | CN | disclosed |
| WO-2024224080-A1 | METHOD OF PRODUCING STYRYLPYRONES AND CHALCONES | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| WO-2012126789-A1 | PRODUCTION OF CHLOROGENIC AND DACTYLIFRIC ACID SPECIES | NESTEC S.A. (CH) | 2012-09-27 | — | — | WO | disclosed |
| CN-102238956-A | Combination therapy comprising kiwifruit and steroids and uses thereof | EFFICAS INC | 2011-11-09 | — | — | CN | disclosed |
| EP-2249849-A1 | COMBINATION THERAPY COMPRISING ACTINIDIA AND STEROIDS AND USES THEREOF | Efficas, Inc. (US) | 2010-11-17 | — | — | EP | disclosed |
| US-20100111927-A1 | Compositions Comprising Actinidia and Methods of Use Thereof | KIM SUNYOUNG | 2010-05-06 | — | — | US | disclosed |
| WO-2009091915-A1 | COMBINATION THERAPY COMPRISING ACTINIDIA AND STEROIDS AND USES THEREOF | EFFICAS, INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| CN-101291679-A | Compositions comprising actinidia and methods of use thereof | EFFICAS INC PANGENOMICS CO LTD (US) | 2008-10-22 | — | — | CN | disclosed |
| US-20080175888-A1 | Combination Therapy Comprising Actinidia and Steroids and Uses Thereof | EFFICAS, INC. | 2008-07-24 | — | — | US | disclosed |
| EP-1858535-A2 | COMPOSITIONS COMPRISING ACTINIDIA AND METHODS OF USE THEREOF | Efficas, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006093793-A2 | COMPOSITIONS COMPRISING ACTINIDIA AND METHODS OF USE THEREOF | EFFICAS, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085054-A1 | DERIVATIVE OF HISPIDIN FROM SANGHUANGPORUS SANGHUANG, AND PREPARATION METHOD AND USE THEREOF | SDHA, HRH2, SDHB | MAOB 1516/4885NFE2L2 3049/4885TRPA1 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.